Ultragenyx Pharma (RARE) Misses Q1 EPS by 6c
Ultragenyx Pharma (NASDAQ: RARE) reported Q1 EPS of ($1.35), $0.06 worse than the analyst estimate of ($1.29).
For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.
Ultragenyx Pharma (NASDAQ: RARE) reported Q1 EPS of ($1.35), $0.06 worse than the analyst estimate of ($1.29).
For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.